总时间（秒）：12.04
问答时间（秒）：9.96

Based on the provided literature, I will extract and standardize the information according to the predefined JSON framework.

**Variants Include**

*   **Gene:** SNCA
*   **variants**
    *   {
            **HGVS**: NM_000345.6:c.158C>T (standardized via API)
            **cDNA Change**
                *   **transcript**: NM_000345.6
                *   **ref**: C
                *   **alt**: T
                *   **position**: 158
            **Protein Change**
                *   **ref**: P
                *   **alt**: L
                *   **position**: 53
            **Description in input context**: c.158C>T (p.P53L)
        }

**Described Disease**

*   **Described Disease:** Parkinson Disease
*   **MONDO**: MONDO:0005417 (retrieved from the MONDO database)

**Experiment Method**

*   **Assay Method:** Western Blot
*   **Material used**
    *   **Material Source:** Lymphoblastoid cell line and patient-derived blood cells
    *   **Material Name:** N.D.
    *   **Description**: The experiment was conducted using lymphoblastoid cell lines and patient-derived blood cells.
*   **Readout type:** Quantitative
*   **Readout description**:
    *   [
            {
                **Variant**: NM_000345.6:c.158C>T
                **Conclusion**: Abnormal
                **Molecular Effect**: N.D.
                **Result Description**: Expression levels of the SNCA wild-type allele were increased, while expression levels of the mutated p.Ala53Thr allele were decreased.
            }
        ]
*   **Biological replicates**
    *   **Biological replicates**: Yes
    *   **Description**: Three biological replicates were performed for patient-derived blood cells.
*   **Technical replicates**
    *   **Technical replicates**: No
    *   **Description**: N.D.
*   **Basic positive control**
    *   **Basic positive control**: Yes
    *   **Description**: Wild-type cDNA was used as a positive control for the SNCA gene.
*   **Basic negative control**
    *   **Basic negative control**: No
    *   **Description**: N.D.
*   **Validation controls P/LP**
    *   **Validation controls P/LP**: No
    *   **Counts**: N.D.
*   **Validation controls B/LB**
    *   **Validation controls B/LB**: No
    *   **Counts**: N.D.
*   **Statistical analysis method**
    *   **Statistical analysis method**: Not specified
    *   **Description**: N.D.
*   **Threshold for normal readout**
    *   **Threshold for normal readout**: Expression levels of the SNCA wild-type allele were greater than 80% in all samples.
    *   **Source**: Literature (custom)
*   **Threshold for abnormal readout**
    *   **Threshold for abnormal readout**: Expression levels of the mutated p.Ala53Thr allele were less than 50% in all samples.
    *   **Source**: Literature (custom)
*   **Approved assay**
    *   **Approved assay**: Yes

Note: The HGVS nomenclature was standardized using the API, but the cDNA changes and protein changes were not explicitly mentioned in the literature.